{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:59:48Z","timestamp":1767085188387,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.saa.2022.121012","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T02:06:45Z","timestamp":1644199605000},"page":"121012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir"],"prefix":"10.1016","volume":"272","author":[{"given":"Sherif","family":"Ramzy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed H.","family":"Abdelazim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.saa.2022.121012_b0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/liv.13266","article-title":"Real life Egyptian experience of efficacy and safety of Simeprevir\/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients","volume":"37","author":"Eletreby","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.saa.2022.121012_b0010","first-page":"490","article-title":"Sofosbuvir and simeprevir combination therapy for HCV genotype 1 infection: Results of a single-center VA experience","volume":"12","author":"Sclair","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.saa.2022.121012_b0015","unstructured":"World health organization (WHO) guidelines for the screening, care and treatment of persons with chronic hepatitis C infection, Updated version, April,2016. Guidelines."},{"key":"10.1016\/j.saa.2022.121012_b0020","doi-asserted-by":"crossref","unstructured":"G.R. de Medeiros, I.C.C. Farias, J.V.C. Farias, P.R. de Macedo, Anti-HCV antiviral therapies as an alternative for the treatment of Covid-19, Res. Soc. Dev. 9(2020) e9489109406-e9489109406. https:\/\/doi.org\/10.33448\/rsd-v9i10.9406.","DOI":"10.33448\/rsd-v9i10.9406"},{"issue":"1","key":"10.1016\/j.saa.2022.121012_b0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/19336950.2020.1837439","article-title":"Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment","volume":"14","author":"Alothaid","year":"2020","journal-title":"Channels"},{"issue":"5","key":"10.1016\/j.saa.2022.121012_b0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acscentsci.0c01186","article-title":"Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir","volume":"7","author":"Lo","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"10","key":"10.1016\/j.saa.2022.121012_b0035","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discovery Today"},{"issue":"9","key":"10.1016\/j.saa.2022.121012_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02680-20","article-title":"Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro","volume":"65","author":"Gammeltoft","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.saa.2022.121012_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchromb.2014.02.028","article-title":"Determination of simeprevir: A novel, hepatitis C protease inhibitor in human plasma by high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"958","author":"Vanwelkenhuysen","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2022.121012_b0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpba.2016.01.019","article-title":"Development of a simple HPLC\u2013UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma","volume":"121","author":"Nannetti","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2022.121012_b0055","doi-asserted-by":"crossref","first-page":"104372","DOI":"10.1016\/j.microc.2019.104372","article-title":"Sensitive spectrofluorimetric assay based on micelle enhanced protocol for the determination of hepatitis C antiviral agent (simeprevir): Application to dosage form and human plasma","volume":"152","author":"Mohammed","year":"2020","journal-title":"Microchem. J."},{"issue":"4","key":"10.1016\/j.saa.2022.121012_b0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/1573411015666181217121619","article-title":"Development and Validation of a New Method for the Determination of Anti-hepatitis C Agent Simeprevir in Human Plasma using HPLC with Fluorescence Detection","volume":"16","author":"Youssef","year":"2020","journal-title":"Curr. Anal. Chem."},{"issue":"36","key":"10.1016\/j.saa.2022.121012_b0065","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.1039\/D0RA01172J","article-title":"Stress stability study of simeprevir, a hepatitis C virus inhibitor, using feasible TLC-spectro-densitometry: application to pharmaceutical dosage form and human plasma","volume":"10","author":"Mohammed","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.saa.2022.121012_b0070","doi-asserted-by":"crossref","unstructured":"S.AN. Abdel-Gawad, Simple chromatographic and spectrophotometric determination of sofosbuvir in pure and tablet forms, Eur. J. Chem. 7(2016) 375-379. https:\/\/doi.org\/10.5155\/eurjchem.7.3.375-379.1439.","DOI":"10.5155\/eurjchem.7.3.375-379.1439"},{"key":"10.1016\/j.saa.2022.121012_b0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5740\/jaoacint.16-0295","article-title":"Comparative validation of the determination of sofosbuvir in pharmaceuticals by several inexpensive ecofriendly chromatographic, electrophoretic, and spectrophotometric methods","volume":"100","author":"El-Yazbi","year":"2017","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2022.121012_b0080","first-page":"114","article-title":"Validated ultraviolet-spectrometric method for determination of sofosbuvir in tablets formulation","volume":"7","author":"El Hamd","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.saa.2022.121012_b0085","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bmc.3690","article-title":"Novel and sensitive UPLC\u2013MS\/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study","volume":"30","author":"Rezk","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"9","key":"10.1016\/j.saa.2022.121012_b0090","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/chromsci\/bmw119","article-title":"Stability-indicating method and LC\u2013MS-MS characterization of forced degradation products of sofosbuvir","volume":"54","author":"Nebsen","year":"2016","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2022.121012_b0095","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/chromsci\/bmab034","article-title":"Feasible TLC-Spectro-Densitometry Technique for Simultaneous Determination of Two Hepatitis C Antiviral Drugs, Sofosbuvir and Simeprevir: Application to Combined Pharmaceutical Dosage Forms and Human Plasma","volume":"59","author":"Mohammed","year":"2021","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2022.121012_b0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.saa.2018.07.017","article-title":"Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and\/or ledipasvir utilizing direct and H-point standard addition strategies","volume":"210","author":"Mohamed","year":"2019","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121012_b0105","unstructured":"Q.B. International Conference on Harmonization (ICH), Federal Register, 62(1997)."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:59:57Z","timestamp":1761357597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142522001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":21,"alternative-id":["S1386142522001603"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2022.121012","relation":{},"ISSN":["1386-1425"],"issn-type":[{"type":"print","value":"1386-1425"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2022.121012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121012"}}